کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5701409 | 1601570 | 2016 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
The right amount of chemotherapy in non-curable disease: Insights from health economics
ترجمه فارسی عنوان
مقدار مناسب شیمی درمانی در بیماری غیر قابل درمان: بینش از اقتصاد سلامت
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
تومور شناسی
چکیده انگلیسی
This article applies concepts from health economics to address what is the “right” amount of chemotherapy in non-curable disease. A health economics perspective is beneficial because it forces a focus on objectives and constraints. We review and apply the concepts of “Choice of Comparator”, “Use of QALYs” and “Equating Marginal Benefit to Marginal Cost”, demonstrating their fit for purpose when considering the optimal amount of chemotherapy for non-curable disease. Many efforts underway to improve healthcare can be viewed as applications of these key economic principles. The true value is in the concepts themselves and not in the associated calculations. Given the difference between a population and a patient perspective, different “optimal” amounts of chemotherapy may exist. For many, however, best may not be most. Optimal decisions may vary depending on whether the goal of treatment is to maximize hope or health.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Cancer Policy - Volume 10, December 2016, Pages 30-35
Journal: Journal of Cancer Policy - Volume 10, December 2016, Pages 30-35
نویسندگان
Jeffrey S. Hoch, Jaclyn Beca, Charlotte Chamberlain, Kelvin K.W. Chan,